HeimLH • NYSE
add
Labcorp Holdings Inc
241,28 $
Eftir lokun(0,00%)0,00
241,28 $
Lokað: 1. maí, 16:25:00 GMT-4 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
241,01 $
Dagbil
235,81 $ - 243,12 $
Árabil
191,97 $ - 258,59 $
Markaðsvirði
20,20 ma. USD
Meðalmagn
899,28 þ.
V/H-hlutf.
27,83
A/V-hlutfall
1,19%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | des. 2024info | Breyting á/á |
---|---|---|
Tekjur | 3,33 ma. | 9,76% |
Rekstrarkostnaður | 665,60 m. | 10,38% |
Nettótekjur | 143,40 m. | 185,82% |
Hagnaðarhlutfall | 4,31 | 178,22% |
Hagnaður á hvern hlut | 3,45 | 4,55% |
EBITDA | 321,20 m. | 8,77% |
Virkt skatthlutfall | 21,87% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | des. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 1,52 ma. | 182,92% |
Heildareignir | 18,38 ma. | 9,89% |
Heildarskuldir | 10,31 ma. | 16,73% |
Eigið fé alls | 8,07 ma. | — |
Útistandandi hlutabréf | 83,70 m. | — |
Eiginfjárgengi | 2,50 | — |
Arðsemi eigna | 3,12% | — |
Ávöxtun eigin fjár | 3,68% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | des. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 143,40 m. | 185,82% |
Handbært fé frá rekstri | 777,20 m. | 34,09% |
Reiðufé frá fjárfestingum | -209,60 m. | 36,60% |
Reiðufé frá fjármögnun | -546,70 m. | -22,44% |
Breyting á handbæru fé | 1,40 m. | 100,73% |
Frjálst peningaflæði | 620,36 m. | 44,57% |
Um
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
Framkvæmdastjóri
Stofnsett
1978
Höfuðstöðvar
Vefsvæði
Starfsfólk
65.450